Related Experiment Video
Updated: Oct 12, 2025
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.8K
Bempedoic acid: LDL-C lowering without adverse reactions.
1Kami R. Whitney practices at Arjun Medical Center in Gainesville, Va. The author has disclosed no potential conflicts of interest, financial or otherwise.
JAAPA : Official Journal of the American Academy of Physician Assistants
|November 23, 2021
Summary
Bempedoic acid offers an effective and well-tolerated treatment for hyperlipidemia, especially for patients unable to use statins. This cholesterol-lowering drug targets LDL-C without causing muscle-related side effects.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Low-density lipoprotein-cholesterol (LDL-C) is a primary driver of atherosclerosis and cardiovascular mortality.
- Statins are standard lipid-lowering therapy but are not tolerated by all patients, creating a treatment gap.
Purpose of the Study:
- To evaluate bempedoic acid as a therapeutic option for hyperlipidemia.
- To assess its efficacy and tolerability, particularly in statin-intolerant patients.
Main Methods:
- A meta-analysis was conducted to synthesize data on bempedoic acid's lipid-lowering effects.
- The analysis included studies of bempedoic acid as monotherapy and in combination with other agents.
Main Results:
- Bempedoic acid demonstrated effective lipid lowering in patients with hyperlipidemia.
- It was well-tolerated, both alone and with other lipid-lowering drugs.
- Unlike statins, bempedoic acid does not appear to cause muscular adverse reactions.
Conclusions:
- Bempedoic acid represents a valuable and safe addition to the hyperlipidemia treatment landscape.
- It effectively addresses the needs of patients with hyperlipidemia, including those intolerant to statins.
More Related Videos
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
946
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
946
01:26Atherosclerosis III: Management
63
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
778
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
778
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
1.1K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.1K
01:26Coronary Artery Disease IV: Preventive Measures
390
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
390
01:21Drugs for Treatment of Constipation-Predominant IBS
382
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
382